nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—saliva—bipolar disorder	0.0221	0.0549	CbGeAlD
Gefitinib—STK10—blood plasma—bipolar disorder	0.0132	0.0329	CbGeAlD
Gefitinib—CYP2C19—urine—bipolar disorder	0.013	0.0323	CbGeAlD
Gefitinib—SBK1—thyroid gland—bipolar disorder	0.0114	0.0283	CbGeAlD
Gefitinib—CYP2C9—urine—bipolar disorder	0.0101	0.0251	CbGeAlD
Gefitinib—CHEK2—thyroid gland—bipolar disorder	0.0099	0.0246	CbGeAlD
Gefitinib—CSNK1E—adrenal cortex—bipolar disorder	0.00901	0.0224	CbGeAlD
Gefitinib—SBK1—cerebellum—bipolar disorder	0.009	0.0224	CbGeAlD
Gefitinib—IRAK4—adrenal cortex—bipolar disorder	0.00887	0.0221	CbGeAlD
Gefitinib—MKNK2—adrenal cortex—bipolar disorder	0.00827	0.0206	CbGeAlD
Gefitinib—MKNK1—adrenal cortex—bipolar disorder	0.00816	0.0203	CbGeAlD
Gefitinib—CYP3A4—urine—bipolar disorder	0.00768	0.0191	CbGeAlD
Gefitinib—CYP2D6—urine—bipolar disorder	0.00756	0.0188	CbGeAlD
Gefitinib—EPHA6—nervous system—bipolar disorder	0.00747	0.0186	CbGeAlD
Gefitinib—SBK1—brain—bipolar disorder	0.00731	0.0182	CbGeAlD
Gefitinib—HIPK4—brain—bipolar disorder	0.00722	0.018	CbGeAlD
Gefitinib—MAP3K19—nervous system—bipolar disorder	0.00679	0.0169	CbGeAlD
Gefitinib—CYP2C19—blood plasma—bipolar disorder	0.00678	0.0169	CbGeAlD
Gefitinib—EGFR—thyroid gland—bipolar disorder	0.00653	0.0162	CbGeAlD
Gefitinib—CHEK2—brain—bipolar disorder	0.00637	0.0158	CbGeAlD
Gefitinib—CSNK1E—thyroid gland—bipolar disorder	0.00628	0.0156	CbGeAlD
Gefitinib—IRAK4—thyroid gland—bipolar disorder	0.00618	0.0154	CbGeAlD
Gefitinib—ERBB3—thyroid gland—bipolar disorder	0.00606	0.0151	CbGeAlD
Gefitinib—MAP2K5—adrenal cortex—bipolar disorder	0.006	0.0149	CbGeAlD
Gefitinib—MKNK2—thyroid gland—bipolar disorder	0.00576	0.0143	CbGeAlD
Gefitinib—IRAK1—thyroid gland—bipolar disorder	0.00576	0.0143	CbGeAlD
Gefitinib—EPHA6—brain—bipolar disorder	0.00571	0.0142	CbGeAlD
Gefitinib—MKNK1—thyroid gland—bipolar disorder	0.00569	0.0141	CbGeAlD
Gefitinib—CYP3A5—blood plasma—bipolar disorder	0.00534	0.0133	CbGeAlD
Gefitinib—CSNK1E—nervous system—bipolar disorder	0.00528	0.0131	CbGeAlD
Gefitinib—CYP2C9—blood plasma—bipolar disorder	0.00526	0.0131	CbGeAlD
Gefitinib—IRAK4—nervous system—bipolar disorder	0.0052	0.0129	CbGeAlD
Gefitinib—MAP3K19—brain—bipolar disorder	0.00519	0.0129	CbGeAlD
Gefitinib—EGFR—cerebellum—bipolar disorder	0.00517	0.0129	CbGeAlD
Gefitinib—ERBB3—nervous system—bipolar disorder	0.00509	0.0127	CbGeAlD
Gefitinib—CSNK1E—cerebellum—bipolar disorder	0.00497	0.0124	CbGeAlD
Gefitinib—IRAK4—cerebellum—bipolar disorder	0.00489	0.0122	CbGeAlD
Gefitinib—MKNK2—nervous system—bipolar disorder	0.00484	0.012	CbGeAlD
Gefitinib—ERBB3—cerebellum—bipolar disorder	0.00479	0.0119	CbGeAlD
Gefitinib—MKNK1—nervous system—bipolar disorder	0.00478	0.0119	CbGeAlD
Gefitinib—STK10—thyroid gland—bipolar disorder	0.00468	0.0116	CbGeAlD
Gefitinib—MKNK2—cerebellum—bipolar disorder	0.00456	0.0113	CbGeAlD
Gefitinib—IRAK1—cerebellum—bipolar disorder	0.00456	0.0113	CbGeAlD
Gefitinib—MKNK1—cerebellum—bipolar disorder	0.0045	0.0112	CbGeAlD
Gefitinib—EGFR—brain—bipolar disorder	0.0042	0.0104	CbGeAlD
Gefitinib—MAP2K5—thyroid gland—bipolar disorder	0.00418	0.0104	CbGeAlD
Gefitinib—CSNK1E—brain—bipolar disorder	0.00404	0.01	CbGeAlD
Gefitinib—CYP3A4—blood plasma—bipolar disorder	0.00401	0.00997	CbGeAlD
Gefitinib—IRAK4—brain—bipolar disorder	0.00397	0.00988	CbGeAlD
Gefitinib—CYP2D6—blood plasma—bipolar disorder	0.00394	0.00981	CbGeAlD
Gefitinib—STK10—nervous system—bipolar disorder	0.00394	0.0098	CbGeAlD
Gefitinib—ERBB3—brain—bipolar disorder	0.00389	0.00969	CbGeAlD
Gefitinib—STK10—cerebellum—bipolar disorder	0.00371	0.00922	CbGeAlD
Gefitinib—MKNK2—brain—bipolar disorder	0.0037	0.00921	CbGeAlD
Gefitinib—IRAK1—brain—bipolar disorder	0.0037	0.00921	CbGeAlD
Gefitinib—MKNK1—brain—bipolar disorder	0.00366	0.00909	CbGeAlD
Gefitinib—Minaprine—MAOA—bipolar disorder	0.00363	0.0995	CrCbGaD
Gefitinib—MAP2K5—nervous system—bipolar disorder	0.00352	0.00875	CbGeAlD
Gefitinib—MAP2K5—cerebellum—bipolar disorder	0.00331	0.00823	CbGeAlD
Gefitinib—Minaprine—DRD1—bipolar disorder	0.0033	0.0905	CrCbGaD
Gefitinib—STK10—brain—bipolar disorder	0.00301	0.00749	CbGeAlD
Gefitinib—ABCG2—adrenal cortex—bipolar disorder	0.00292	0.00726	CbGeAlD
Gefitinib—ORM1—nervous system—bipolar disorder	0.00286	0.0071	CbGeAlD
Gefitinib—Iloperidone—DRD4—bipolar disorder	0.00284	0.078	CrCbGaD
Gefitinib—ABCB1—blood plasma—bipolar disorder	0.00284	0.00706	CbGeAlD
Gefitinib—Minaprine—HTR2C—bipolar disorder	0.00282	0.0774	CrCbGaD
Gefitinib—MAP2K5—brain—bipolar disorder	0.00269	0.00669	CbGeAlD
Gefitinib—Iloperidone—DRD3—bipolar disorder	0.00245	0.0672	CrCbGaD
Gefitinib—Iloperidone—DRD1—bipolar disorder	0.00241	0.066	CrCbGaD
Gefitinib—Minaprine—SLC6A4—bipolar disorder	0.00234	0.0641	CrCbGaD
Gefitinib—Minaprine—DRD2—bipolar disorder	0.00233	0.0638	CrCbGaD
Gefitinib—Cisapride—HTR2C—bipolar disorder	0.00223	0.0612	CrCbGaD
Gefitinib—Iloperidone—HTR2C—bipolar disorder	0.00206	0.0565	CrCbGaD
Gefitinib—ABCG2—thyroid gland—bipolar disorder	0.00203	0.00506	CbGeAlD
Gefitinib—Iloperidone—HTR1A—bipolar disorder	0.002	0.0548	CrCbGaD
Gefitinib—CYP1A1—thyroid gland—bipolar disorder	0.00193	0.0048	CbGeAlD
Gefitinib—ALB—brain—bipolar disorder	0.00191	0.00476	CbGeAlD
Gefitinib—Cisapride—DRD2—bipolar disorder	0.00184	0.0504	CrCbGaD
Gefitinib—Minaprine—HTR2A—bipolar disorder	0.0018	0.0493	CrCbGaD
Gefitinib—Iloperidone—DRD2—bipolar disorder	0.0017	0.0465	CrCbGaD
Gefitinib—CYP1A1—nervous system—bipolar disorder	0.00162	0.00404	CbGeAlD
Gefitinib—ABCG2—cerebellum—bipolar disorder	0.00161	0.00401	CbGeAlD
Gefitinib—ABCB1—adrenal cortex—bipolar disorder	0.00144	0.00358	CbGeAlD
Gefitinib—Cisapride—HTR2A—bipolar disorder	0.00142	0.039	CrCbGaD
Gefitinib—Iloperidone—HTR2A—bipolar disorder	0.00131	0.036	CrCbGaD
Gefitinib—ABCG2—brain—bipolar disorder	0.00131	0.00325	CbGeAlD
Gefitinib—CYP1A1—brain—bipolar disorder	0.00124	0.00309	CbGeAlD
Gefitinib—CYP3A4—nervous system—bipolar disorder	0.00119	0.00297	CbGeAlD
Gefitinib—CYP2D6—nervous system—bipolar disorder	0.00117	0.00292	CbGeAlD
Gefitinib—CYP2D6—cerebellum—bipolar disorder	0.0011	0.00275	CbGeAlD
Gefitinib—ABCB1—thyroid gland—bipolar disorder	0.001	0.0025	CbGeAlD
Gefitinib—CYP2D6—brain—bipolar disorder	0.000897	0.00223	CbGeAlD
Gefitinib—ABCB1—nervous system—bipolar disorder	0.000844	0.0021	CbGeAlD
Gefitinib—ABCB1—cerebellum—bipolar disorder	0.000794	0.00198	CbGeAlD
Gefitinib—ABCB1—brain—bipolar disorder	0.000645	0.0016	CbGeAlD
Gefitinib—CYP3A5—Metabolism—NCAN—bipolar disorder	9.67e-05	0.000172	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD3—bipolar disorder	9.66e-05	0.000172	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2A—bipolar disorder	9.64e-05	0.000172	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—IMPA1—bipolar disorder	9.63e-05	0.000172	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—GSK3A—bipolar disorder	9.62e-05	0.000171	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—S100B—bipolar disorder	9.58e-05	0.000171	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CLOCK—bipolar disorder	9.56e-05	0.00017	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NR1D1—bipolar disorder	9.55e-05	0.00017	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-E—bipolar disorder	9.54e-05	0.00017	CbGpPWpGaD
Gefitinib—EGFR—Disease—SNAP25—bipolar disorder	9.52e-05	0.00017	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NTRK1—bipolar disorder	9.5e-05	0.000169	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SLC5A3—bipolar disorder	9.47e-05	0.000169	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	9.41e-05	0.000168	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—IMPA2—bipolar disorder	9.4e-05	0.000167	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD4—bipolar disorder	9.38e-05	0.000167	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TSHB—bipolar disorder	9.31e-05	0.000166	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TPH2—bipolar disorder	9.31e-05	0.000166	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNB2—bipolar disorder	9.31e-05	0.000166	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—S100B—bipolar disorder	9.23e-05	0.000164	CbGpPWpGaD
Gefitinib—EGFR—Disease—GSK3A—bipolar disorder	9.18e-05	0.000164	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—DPYD—bipolar disorder	9.16e-05	0.000163	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—GSK3B—bipolar disorder	9.15e-05	0.000163	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NCAN—bipolar disorder	9.13e-05	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ADCY2—bipolar disorder	9.13e-05	0.000163	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NDUFV2—bipolar disorder	8.98e-05	0.00016	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TRPC3—bipolar disorder	8.97e-05	0.00016	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SLC5A3—bipolar disorder	8.95e-05	0.000159	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADCY2—bipolar disorder	8.83e-05	0.000157	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TCF7L2—bipolar disorder	8.79e-05	0.000157	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NDUFV2—bipolar disorder	8.77e-05	0.000156	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—GSK3B—bipolar disorder	8.75e-05	0.000156	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	8.74e-05	0.000156	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD2—bipolar disorder	8.73e-05	0.000156	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NR1D1—bipolar disorder	8.7e-05	0.000155	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AKR1C4—bipolar disorder	8.7e-05	0.000155	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ADCY2—bipolar disorder	8.68e-05	0.000155	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADM—bipolar disorder	8.56e-05	0.000152	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNA1C—bipolar disorder	8.52e-05	0.000152	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AKR1C4—bipolar disorder	8.49e-05	0.000151	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NRG1—bipolar disorder	8.45e-05	0.000151	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL1B—bipolar disorder	8.45e-05	0.00015	CbGpPWpGaD
Gefitinib—ERBB3—Disease—GSK3B—bipolar disorder	8.45e-05	0.00015	CbGpPWpGaD
Gefitinib—EGFR—Disease—ADCY2—bipolar disorder	8.43e-05	0.00015	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—GSK3B—bipolar disorder	8.4e-05	0.00015	CbGpPWpGaD
Gefitinib—EGFR—Disease—TCF7L2—bipolar disorder	8.4e-05	0.00015	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSHB—bipolar disorder	8.34e-05	0.000149	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TACR1—bipolar disorder	8.34e-05	0.000149	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PDE4B—bipolar disorder	8.34e-05	0.000149	CbGpPWpGaD
Gefitinib—ERBB3—Disease—INS—bipolar disorder	8.33e-05	0.000148	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NCAN—bipolar disorder	8.33e-05	0.000148	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PIK3C2A—bipolar disorder	8.3e-05	0.000148	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NDUFV2—bipolar disorder	8.26e-05	0.000147	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NDUFV2—bipolar disorder	8.19e-05	0.000146	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SLC5A3—bipolar disorder	8.16e-05	0.000145	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NRG1—bipolar disorder	8.15e-05	0.000145	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AKR1C4—bipolar disorder	8e-05	0.000142	CbGpPWpGaD
Gefitinib—EGFR—Immune System—S100B—bipolar disorder	7.95e-05	0.000142	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AKR1C4—bipolar disorder	7.93e-05	0.000141	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NTRK1—bipolar disorder	7.91e-05	0.000141	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NR1D1—bipolar disorder	7.81e-05	0.000139	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—GSK3B—bipolar disorder	7.76e-05	0.000138	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—POMC—bipolar disorder	7.7e-05	0.000137	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—S100B—bipolar disorder	7.69e-05	0.000137	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	7.66e-05	0.000136	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—INS—bipolar disorder	7.66e-05	0.000136	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NR1D1—bipolar disorder	7.63e-05	0.000136	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2A—bipolar disorder	7.62e-05	0.000136	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—GSK3B—bipolar disorder	7.62e-05	0.000136	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	7.61e-05	0.000135	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NCAN—bipolar disorder	7.47e-05	0.000133	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SNAP25—bipolar disorder	7.44e-05	0.000133	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2A—bipolar disorder	7.35e-05	0.000131	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SLC5A3—bipolar disorder	7.32e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NCAN—bipolar disorder	7.29e-05	0.00013	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NR1D1—bipolar disorder	7.19e-05	0.000128	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SLC5A3—bipolar disorder	7.15e-05	0.000127	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NR1D1—bipolar disorder	7.12e-05	0.000127	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—POMC—bipolar disorder	7.1e-05	0.000127	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NRG1—bipolar disorder	7.02e-05	0.000125	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2A—bipolar disorder	6.92e-05	0.000123	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1A—bipolar disorder	6.9e-05	0.000123	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NCAN—bipolar disorder	6.87e-05	0.000122	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CLOCK—bipolar disorder	6.85e-05	0.000122	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NCAN—bipolar disorder	6.81e-05	0.000121	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TAC1—bipolar disorder	6.8e-05	0.000121	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NRG1—bipolar disorder	6.78e-05	0.000121	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—bipolar disorder	6.74e-05	0.00012	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SLC5A3—bipolar disorder	6.73e-05	0.00012	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SLC5A3—bipolar disorder	6.68e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TPH2—bipolar disorder	6.67e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TSHB—bipolar disorder	6.67e-05	0.000119	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNB2—bipolar disorder	6.67e-05	0.000119	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2C—bipolar disorder	6.67e-05	0.000119	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD1—bipolar disorder	6.67e-05	0.000119	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADCY2—bipolar disorder	6.59e-05	0.000117	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DPYD—bipolar disorder	6.56e-05	0.000117	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NTRK2—bipolar disorder	6.49e-05	0.000116	CbGpPWpGaD
Gefitinib—EGFR—Disease—NRG1—bipolar disorder	6.48e-05	0.000115	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CLOCK—bipolar disorder	6.47e-05	0.000115	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD3—bipolar disorder	6.46e-05	0.000115	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GSK3A—bipolar disorder	6.43e-05	0.000115	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—IMPA1—bipolar disorder	6.35e-05	0.000113	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TPH2—bipolar disorder	6.3e-05	0.000112	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TSHB—bipolar disorder	6.3e-05	0.000112	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNB2—bipolar disorder	6.3e-05	0.000112	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD4—bipolar disorder	6.27e-05	0.000112	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DPYD—bipolar disorder	6.2e-05	0.00011	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—GSK3B—bipolar disorder	6.14e-05	0.000109	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2A—bipolar disorder	6.12e-05	0.000109	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNA1C—bipolar disorder	6.1e-05	0.000109	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—POMC—bipolar disorder	6.09e-05	0.000108	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—INS—bipolar disorder	6.05e-05	0.000108	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	5.95e-05	0.000106	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—GSK3B—bipolar disorder	5.92e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADCY2—bipolar disorder	5.9e-05	0.000105	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CLOCK—bipolar disorder	5.9e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TCF7L2—bipolar disorder	5.88e-05	0.000105	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—bipolar disorder	5.87e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD2—bipolar disorder	5.84e-05	0.000104	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—INS—bipolar disorder	5.84e-05	0.000104	CbGpPWpGaD
Gefitinib—EGFR—Disease—MTHFR—bipolar disorder	5.83e-05	0.000104	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNA1C—bipolar disorder	5.77e-05	0.000103	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TPH2—bipolar disorder	5.75e-05	0.000102	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNB2—bipolar disorder	5.75e-05	0.000102	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TSHB—bipolar disorder	5.75e-05	0.000102	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DPYD—bipolar disorder	5.65e-05	0.000101	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—COMT—bipolar disorder	5.64e-05	0.0001	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PIK3C2A—bipolar disorder	5.62e-05	0.0001	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—bipolar disorder	5.61e-05	9.99e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MAOA—bipolar disorder	5.6e-05	9.98e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.54e-05	9.87e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—bipolar disorder	5.53e-05	9.85e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NDUFV2—bipolar disorder	5.4e-05	9.62e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SNAP25—bipolar disorder	5.33e-05	9.5e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CLOCK—bipolar disorder	5.29e-05	9.43e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NTRK1—bipolar disorder	5.29e-05	9.42e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNA1C—bipolar disorder	5.26e-05	9.36e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKR1C4—bipolar disorder	5.23e-05	9.32e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CLOCK—bipolar disorder	5.17e-05	9.2e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TPH2—bipolar disorder	5.16e-05	9.19e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TSHB—bipolar disorder	5.16e-05	9.19e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNB2—bipolar disorder	5.16e-05	9.19e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—S100B—bipolar disorder	5.14e-05	9.16e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PIK3C2A—bipolar disorder	5.12e-05	9.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—GSK3B—bipolar disorder	5.09e-05	9.07e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DPYD—bipolar disorder	5.08e-05	9.04e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	5.05e-05	9e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SNAP25—bipolar disorder	5.04e-05	8.98e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNB2—bipolar disorder	5.03e-05	8.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TPH2—bipolar disorder	5.03e-05	8.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TSHB—bipolar disorder	5.03e-05	8.97e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DPYD—bipolar disorder	4.95e-05	8.82e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—GSK3B—bipolar disorder	4.93e-05	8.77e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—bipolar disorder	4.89e-05	8.7e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CLOCK—bipolar disorder	4.87e-05	8.67e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—INS—bipolar disorder	4.86e-05	8.65e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CLOCK—bipolar disorder	4.83e-05	8.6e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TSHB—bipolar disorder	4.74e-05	8.45e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNB2—bipolar disorder	4.74e-05	8.45e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TPH2—bipolar disorder	4.74e-05	8.45e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADCY2—bipolar disorder	4.72e-05	8.41e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNA1C—bipolar disorder	4.72e-05	8.4e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TSHB—bipolar disorder	4.7e-05	8.38e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNB2—bipolar disorder	4.7e-05	8.38e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TPH2—bipolar disorder	4.7e-05	8.38e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—GSK3B—bipolar disorder	4.7e-05	8.38e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NR1D1—bipolar disorder	4.7e-05	8.37e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DPYD—bipolar disorder	4.67e-05	8.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—INS—bipolar disorder	4.64e-05	8.26e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DPYD—bipolar disorder	4.63e-05	8.24e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNA1C—bipolar disorder	4.61e-05	8.2e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	4.6e-05	8.19e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SNAP25—bipolar disorder	4.59e-05	8.18e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MTHFR—bipolar disorder	4.56e-05	8.12e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NRG1—bipolar disorder	4.54e-05	8.08e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.54e-05	8.08e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NCAN—bipolar disorder	4.49e-05	8e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PIK3C2A—bipolar disorder	4.49e-05	7.99e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADCY2—bipolar disorder	4.46e-05	7.94e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SLC5A3—bipolar disorder	4.4e-05	7.84e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNA1C—bipolar disorder	4.34e-05	7.73e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNA1C—bipolar disorder	4.3e-05	7.66e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	4.23e-05	7.53e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	4.19e-05	7.47e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.14e-05	7.37e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SNAP25—bipolar disorder	4.12e-05	7.35e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—bipolar disorder	4.09e-05	7.29e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADCY2—bipolar disorder	4.07e-05	7.24e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—COMT—bipolar disorder	4.04e-05	7.2e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SNAP25—bipolar disorder	4.03e-05	7.17e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MAOA—bipolar disorder	4.01e-05	7.15e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—COMT—bipolar disorder	3.82e-05	6.8e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SNAP25—bipolar disorder	3.79e-05	6.76e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MAOA—bipolar disorder	3.79e-05	6.75e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SNAP25—bipolar disorder	3.76e-05	6.7e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—bipolar disorder	3.75e-05	6.68e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADCY2—bipolar disorder	3.65e-05	6.5e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—bipolar disorder	3.65e-05	6.5e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—INS—bipolar disorder	3.63e-05	6.46e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADCY2—bipolar disorder	3.56e-05	6.34e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—COMT—bipolar disorder	3.48e-05	6.2e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MAOA—bipolar disorder	3.46e-05	6.16e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADCY2—bipolar disorder	3.36e-05	5.98e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADCY2—bipolar disorder	3.33e-05	5.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GSK3B—bipolar disorder	3.29e-05	5.87e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MTHFR—bipolar disorder	3.27e-05	5.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—bipolar disorder	3.27e-05	5.82e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—INS—bipolar disorder	3.25e-05	5.79e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CLOCK—bipolar disorder	3.18e-05	5.67e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—COMT—bipolar disorder	3.13e-05	5.57e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MAOA—bipolar disorder	3.1e-05	5.53e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNB2—bipolar disorder	3.1e-05	5.52e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPH2—bipolar disorder	3.1e-05	5.52e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TSHB—bipolar disorder	3.1e-05	5.52e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MTHFR—bipolar disorder	3.09e-05	5.5e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DPYD—bipolar disorder	3.05e-05	5.44e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—COMT—bipolar disorder	3.05e-05	5.43e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MAOA—bipolar disorder	3.03e-05	5.39e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—COMT—bipolar disorder	2.87e-05	5.12e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MAOA—bipolar disorder	2.85e-05	5.08e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—COMT—bipolar disorder	2.85e-05	5.08e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNA1C—bipolar disorder	2.84e-05	5.05e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOA—bipolar disorder	2.83e-05	5.04e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MTHFR—bipolar disorder	2.81e-05	5.01e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	2.76e-05	4.92e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—bipolar disorder	2.61e-05	4.65e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—INS—bipolar disorder	2.6e-05	4.63e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MTHFR—bipolar disorder	2.53e-05	4.5e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SNAP25—bipolar disorder	2.48e-05	4.42e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—bipolar disorder	2.47e-05	4.4e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MTHFR—bipolar disorder	2.47e-05	4.39e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—INS—bipolar disorder	2.46e-05	4.37e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.32e-05	4.14e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MTHFR—bipolar disorder	2.3e-05	4.1e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—bipolar disorder	2.25e-05	4.01e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—INS—bipolar disorder	2.24e-05	3.99e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADCY2—bipolar disorder	2.19e-05	3.91e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—bipolar disorder	2.02e-05	3.6e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—INS—bipolar disorder	2.01e-05	3.58e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—bipolar disorder	1.97e-05	3.51e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—INS—bipolar disorder	1.96e-05	3.49e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—COMT—bipolar disorder	1.88e-05	3.35e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOA—bipolar disorder	1.87e-05	3.32e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—bipolar disorder	1.86e-05	3.31e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—INS—bipolar disorder	1.85e-05	3.29e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—bipolar disorder	1.84e-05	3.28e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—INS—bipolar disorder	1.83e-05	3.26e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MTHFR—bipolar disorder	1.52e-05	2.71e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—bipolar disorder	1.21e-05	2.16e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—INS—bipolar disorder	1.21e-05	2.15e-05	CbGpPWpGaD
